Antal M
Int J Mol Sci. 2025; 26(5).
PMID: 40076973
PMC: 11900602.
DOI: 10.3390/ijms26052356.
Tummino T, Iliopoulos-Tsoutsouvas C, Braz J, OBrien E, Stein R, Craik V
Nat Commun. 2025; 16(1):2237.
PMID: 40044644
PMC: 11882969.
DOI: 10.1038/s41467-025-57136-7.
Staedtler E, Sapio M, King D, Maric D, Ghetti A, Mannes A
Cell Rep Med. 2024; 5(10):101788.
PMID: 39413733
PMC: 11513826.
DOI: 10.1016/j.xcrm.2024.101788.
Inyang K, Sim J, Clark K, Geron M, Monahan K, Evans C
Brain Behav Immun. 2024; 123:399-410.
PMID: 39349285
PMC: 11624093.
DOI: 10.1016/j.bbi.2024.09.031.
Alexander R, Bender K
bioRxiv. 2024; .
PMID: 39149233
PMC: 11326311.
DOI: 10.1101/2024.08.08.607246.
Morphine acts in vitro to directly prime nociceptors.
Khomula E, Levine J
Mol Pain. 2024; 20:17448069241260348.
PMID: 38828868
PMC: 11149440.
DOI: 10.1177/17448069241260348.
Regulatory T cell-derived enkephalin gates nociception.
Midavaine E, Moraes B, Benitez J, Rodriguez S, Braz J, Kochhar N
bioRxiv. 2024; .
PMID: 38798460
PMC: 11118376.
DOI: 10.1101/2024.05.11.593442.
Selective targeting of mu opioid receptors to primary cilia.
Fagan R, Lee D, Geron M, Scherrer G, Von Zastrow M, Ehrlich A
Cell Rep. 2024; 43(5):114164.
PMID: 38678559
PMC: 11257377.
DOI: 10.1016/j.celrep.2024.114164.
The aetiology of social deficits within mental health disorders: The role of the immune system and endogenous opioids.
Charles S, Farias M, Dunbar R
Brain Behav Immun Health. 2024; 1:100003.
PMID: 38377411
PMC: 8474498.
DOI: 10.1016/j.bbih.2019.100003.
Targeting sensory neuron GPCRs for peripheral neuropathic pain.
Uniyal A, Tiwari V, Tsukamoto T, Dong X, Guan Y, Raja S
Trends Pharmacol Sci. 2023; 44(12):1009-1027.
PMID: 37977131
PMC: 10657387.
DOI: 10.1016/j.tips.2023.10.003.
Mu opioid receptors gate the locus coeruleus pain generator.
Norris M, Kuo C, Dunn S, Kim J, Becker L, Borges G
bioRxiv. 2023; .
PMID: 37961541
PMC: 10634678.
DOI: 10.1101/2023.10.20.562785.
Optogenetic and Chemogenic Control of Pain Signaling: Molecular Markers.
Espinosa-Juarez J, Chiquete E, Estanol B, Aceves J
Int J Mol Sci. 2023; 24(12).
PMID: 37373365
PMC: 10299175.
DOI: 10.3390/ijms241210220.
Cell-type specific molecular architecture for mu opioid receptor function in pain and addiction circuits.
Ochandarena N, Niehaus J, Tassou A, Scherrer G
Neuropharmacology. 2023; 238:109597.
PMID: 37271281
PMC: 10494323.
DOI: 10.1016/j.neuropharm.2023.109597.
Extracellular vesicle-mediated delivery of anti-miR-106b inhibits morphine-induced primary ciliogenesis in the brain.
Ma R, Kutchy N, Wang Z, Hu G
Mol Ther. 2023; 31(5):1332-1345.
PMID: 37012704
PMC: 10188913.
DOI: 10.1016/j.ymthe.2023.03.030.
Neurons in the caudal ventrolateral medulla mediate descending pain control.
Gu X, Zhang Y, OMalley J, De Preter C, Penzo M, Hoon M
Nat Neurosci. 2023; 26(4):594-605.
PMID: 36894654
PMC: 11114367.
DOI: 10.1038/s41593-023-01268-w.
Endometriosis and Opioid Receptors: Are Opioids a Possible/Promising Treatment for Endometriosis?.
Guan Q, Velho R, Sehouli J, Mechsner S
Int J Mol Sci. 2023; 24(2).
PMID: 36675147
PMC: 9864914.
DOI: 10.3390/ijms24021633.
Mu-opioid receptor and receptor tyrosine kinase crosstalk: Implications in mechanisms of opioid tolerance, reduced analgesia to neuropathic pain, dependence, and reward.
Gamble M, Williams B, Singh N, Posa L, Freyberg Z, Logan R
Front Syst Neurosci. 2022; 16:1059089.
PMID: 36532632
PMC: 9751598.
DOI: 10.3389/fnsys.2022.1059089.
The Delta-Opioid Receptor Bidirectionally Modulates Itch.
Smith K, Nguyen E, Ross S
J Pain. 2022; 24(2):264-272.
PMID: 36464136
PMC: 10866011.
DOI: 10.1016/j.jpain.2022.09.013.
Somatosensation a la mode: plasticity and polymodality in sensory neurons.
Emery E, Wood J
Curr Opin Physiol. 2022; 11:29-34.
PMID: 36381588
PMC: 7613802.
DOI: 10.1016/j.cophys.2019.04.014.
Structure-based discovery of nonopioid analgesics acting through the α-adrenergic receptor.
Fink E, Xu J, Hubner H, Braz J, Seemann P, Avet C
Science. 2022; 377(6614):eabn7065.
PMID: 36173843
PMC: 10360211.
DOI: 10.1126/science.abn7065.